ALXO (ALXO) Stock Price & Analysis
ALXO (ALXO) fell 0.98% to USD 2.01 as of September 8, 2026 at 04:16 UTC, according to Nexqual real-time market data.
ALXO last closed at USD 2.01; the session ranged USD 2–2.03 on volume of 301,115 shares. Market capitalization is —, with a 52-week range of USD 1.01–2.66 (NMS). Source: Nexqual, September 8, 2026 at 04:16 UTC.
Key Statistics (as of September 8, 2026 at 04:16 UTC)
| Price | USD 2.01 |
|---|---|
| Change | ▼ 0.98% (down) |
| Previous Close | USD 2.01 |
| Open | USD 2.01 |
| Day Range | USD 2 – 2.03 |
| 52-Week Range | USD 1.01 – 2.66 |
| Volume | 301,115 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ALXO)
Nexqual's technical model rates ALXO "BUY" based on 4 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 04:16 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 49.44 (neutral) |
| vs SMA50 | Below (USD 2.03) |
| MACD | 0.01 (positive) |
From ALXO's Latest SEC 10-K Filing (filed 2026-03-09)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NKTX | Nkarta, Inc. | USD 2.92 | ▲ 5.61% |
| ANNX | Annexon, Inc. | USD 4.87 | ▼ 1.22% |
| PMVP | PMV Pharmaceuticals, Inc. | USD 1.29 | ▲ 2.38% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | USD 3.99 | ▲ 5.84% |
| CCCC | C4 Therapeutics, Inc. | USD 3.76 | ▼ 0.79% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:16 UTC. This page is informational and not investment advice.